A similar effect was reported from CAR T cell targeted FAP; a treatment with the FAP-CAR T cells resulted in ~80% depletion of FAP+ cells, which was associated with a significant inhibition of tumor growth (35–50%) in mesothelioma and lung cancer mouse models [84]. The gene discussed is FAP; the disease is lung carcinoma.